Albus, A.; Kronimus, Y.; Burg-Roderfeld, M.; van der Wurp, H.; Willbold, D.; Ziehm, T.; Dodel, R.; Ross, J.A.
The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease. Biomolecules 2023, 13, 1303.
https://doi.org/10.3390/biom13091303
AMA Style
Albus A, Kronimus Y, Burg-Roderfeld M, van der Wurp H, Willbold D, Ziehm T, Dodel R, Ross JA.
The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease. Biomolecules. 2023; 13(9):1303.
https://doi.org/10.3390/biom13091303
Chicago/Turabian Style
Albus, Alexandra, Yannick Kronimus, Monika Burg-Roderfeld, Hendrik van der Wurp, Dieter Willbold, Tamar Ziehm, Richard Dodel, and Jean Alexander Ross.
2023. "The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease" Biomolecules 13, no. 9: 1303.
https://doi.org/10.3390/biom13091303
APA Style
Albus, A., Kronimus, Y., Burg-Roderfeld, M., van der Wurp, H., Willbold, D., Ziehm, T., Dodel, R., & Ross, J. A.
(2023). The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease. Biomolecules, 13(9), 1303.
https://doi.org/10.3390/biom13091303
